In this one-on-one interview with Gluten-Free Living Editorial Director Maureen McCarthy, CEO Marilyn Geller discusses the Foundation’s history, research and outreach goals, and the importance of partnering with GFL.
Accelerating diagnosis, treatments, and a cure for celiac disease and non-celiac gluten sensitivity through research, education, and advocacy.
Learn more and see if you qualify. Participate in a Study to Advance Treatments for Cross-Contact with Gluten
A new study suggests a protein produced by the Epstein-Barr virus can increase the risk of developing celiac disease and six other autoimmune diseases. A group of researchers from Cincinnati, Ohio developed an algorithm to investigate possible links between DNA-binding proteins, called transcription factors, and disease loci in the human genome. A disease locus is […]
In honor of May Celiac Disease Awareness Month, the Celiac Disease Foundation is proud to announce our expanded partnership with the Children’s National Health System Celiac Disease Program, dedicated to improving the way pediatric celiac disease is diagnosed and treated. The Program recently developed the Celiac Disease and Gluten-Free Diet Digital Resource Center to house […]
Patients and caregivers have unique perspectives on the burdens and benefits of various treatment options. As such, their input is invaluable to the drug evaluation process. On April 3, 2018, Celiac Disease Foundation Legislative Analyst, Alana Broe, attended the FDA’s Public Workshop on Keys to Effective Engagement with the Center for Disease Evaluation and Research […]
“I look forward to working together to spotlight celiac disease and gluten-free champions in our community, and to our shared commitment to advance celiac disease research. Gluten-Free Living provides a unique platform to reach the many people following a gluten-free diet who so often feel alone and who struggle to find a supportive community and credible information.”